deltatrials
Not Yet Recruiting OBSERVATIONAL NCT07326059

Safety and Outcomes of MUSE Stem Cell Therapy in Individuals With Traumatic Brain Injury (MUSE-TBI-OBS)

An Observational Study on the Safety and Outcomes of MUSE Stem Cell Therapy in Participants With Traumatic Brain Injury Receiving International Clinical Treatment

Sponsor: Healing Hope International

Conditions Traumatic Brain Injury Traumatic Brain Injury (TBI) Patients Traumatic Brain Injury (TBI); Concussion, Initial Encounter Traumatic Brain Injury (TBI); Concussion, Subsequent Encounter Traumatic Brain Injury With Brief Loss of Consciousness Traumatic Brain Injury With Persistent Cognitive Deficits
Interventions MUSE Stem Cell Therapy
Updated 2 times since 2026 Last updated: Mar 8, 2026 Started: Jan 31, 2028 Primary completion: Dec 31, 2034 Completion: Jun 30, 2036
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07326059, this observational or N/A phase trial focuses on Traumatic Brain Injury and Traumatic Brain Injury (TBI) Patients and remains actively recruiting participants. Sponsored by Healing Hope International, it has been updated 2 times since 2028, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2026 – ~Mar 2026 · 28 days · monthly snapshotNot Yet Recruiting~Mar 2026 – present · 4 months · monthly snapshotNot Yet Recruiting

Change History

2 versions recorded

  1. Mar 2026 — Present [monthly]

    Not Yet Recruiting

  2. Feb 2026 — Mar 2026 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Healing Hope International
Data source: Healing Hope International

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations